Interaction of cefotetan and the metallo-β-lactamases produced in Aeromonas spp. and in vitro activity

Chemotherapy

Volumn 46, Issue 3, 2000, Pages 177-183

  Quiroga, M I ^b   Franceschini, N ^b   Rossolini, G M ^b   Gutkind, G ^b   Bonfiglio, G ^b   Franchino, L ^a   Amicosante, G ^b  

^a ZENECA   (Italy)

^b Dept of Sci and Biomed Technol ^*

Author keywords

Aeromonas metallo lactamases; Cefotetan; Inhibition

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFALOTIN; CEFOTETAN; CEFUROXIME; IMIPENEM; OFLOXACIN;

AEROMONAS; AEROMONAS HYDROPHILA; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG HYDROLYSIS; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0034091235     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007275     Document Type: Article

References (28)

1. Bush K, Jacoby G, Medeiros A: A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39: 1211-1233.
2. Sabath LD, Abraham EP: Zinc as a cofactor for cephalosporinase from Bacillus cereus 569. Biochem J 1966;98:11-13.
3. Sato K, Fujii T, Okamoto R, Inoue M, Mitsuhashi S: Biochemical properties of β-lactamase produced by Flavobacterium odoratum. Antimicrob Agents Chemother 1985;27: 612-614.
4. Fujii T, Sato K, Miyata K, Inoue M, Mitsuhashi S: Biochemical properties of β-lactamase produced by Legionella gormanii. Antimicrob Agents Chemother 1986;29:925-926.
5. Walsh TR, Hall L, Assinder SJ, Nichols WW, Cartwright SJ, Mac Gowan AP, Bennett PM: Sequence and analysis of the L1 metallo-β-lactamase from Xanthomonas maltophilia. Biochim Biophys Acta 1994; 1218:199-201.
6. Marumo K, Takeda A, Nikamura Y, Nakaya K: Purification and characterisation of metallo-β-lactamase from Serratia marcescens. Microbiol Immunol 1995;39:71-78.
7. Cuchural GS Jr, Malamy MH, Tally FP: β-Lactamase-mediated imipenem resistance in Bacteroidesfragilis. Antimicrob Agents Chemother 1986;30:645-648.
8. Watanabe M, Iyobe S, Inoue M, Mitsuhashi S: Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991;365:147-151.
9. O'Hara K, Haruta S, Sawai T, Tsunoda M, Iyobe S: Novel metallo-β-lactamase mediated by a Shigella flexneri plasmid. FEMS Microbiol Lett 1998;162:201-206.
10. Shannon K, King A, Phillips I: β-Lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila. J Antimicroh Chemother 1986;17:45-50.
11. Yang Y, Bush K: Biochemical characterisation of the carbapenem-hydrolyzing β-lactamase Ash MI from Aeromonas sobria AER 14M: A member of a novel subgroup of metallo-β-lactamase. FEMS Microbiol Lett 1996;137:193-200.
12. Rossolini GM, Franceschini N, Riccio ML, Mercuri P, Perilli M. Galleni M, Frere JM, Amicosante G: Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: A new molecular class B β-laclamase showing a broad substrate profile. Biochem J 1998;332:145-152.
13. Ambler RP: The structure of β-lactamascs. Philos Trans R Soc Lond B Biol Sci 1989;289:321-331.
14. Massidda O, Rossolini GM, Satta G: The Acromonas hydrophilia ephA gene: Molecular heterogeneity among class B metallo-β-lactamases. J Bacteriol 1991;173:4611-4617.
15. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility for bacteria that grow aerobically, ed 4. Villanova, National Committee for Clinical Laboratory Standards, 1994, M7-A.
16. Felici A, Amicosante G, Oratore A, Strom R, Ledent P, Joris B, Fanuel L, Frere JM: An overview of the kinetic parameters of class B β-lactamases. Biochem J 1993;291:151-155.
17. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 1976;72: 248-254.
18. De Meester F, Joris B, Reckinger G, Bellefroid-Bourguignon C, Frere JM, Waley SG: Automated analysis of enzyme inactivation phenomena. Biochcm Pharmacol 1987;36:2393-2403.
19. Ko W, Wu H, Chang T, Van J, Wu J: Inducible β-lactam resistance in Acromonas hydrophila: Therapeutic challenge for antimicrobial therapy. J Clin Microbiol 1998;36:3188-3192.
20. Rossolini GM, Walsh T. Amicosante G: The Aeromonas inetallo-β-laetamases: Genetic, enzymology, and contribution to drug resistance. Microb Drug Resist 1996;2:245-252.
21. Felici A, Amicosante G: Extension of substrate specificity with metallo-β-lactamases: A kinetic analysis with Xanthomonas maltophilia. Aeromonas hydrophila and Bacillus cereus enzymes. Antimicrob Agents Chemother 1995;39:192-199.
22. Segatore B, Massida O, Satta G, Setacci D, Amicosante G: High specificity of cphA-encoded metallo-β-lactamase from Aeromonas hydrophila AE036 for carbapenems and its contribution to β-lactam resistance. Antimicrob Agents Chemother 1993;37:1324-1328.
23. 3-cephems: Comparative study with other metallo-β-lactamases. Antimicrob Agents Chemother 1997;41:866-868.
24. Vinogradova M, Kozko T, Petukhov E, Shubina V, Schneiter I, Miroshina T, Vinogradov N, Astafeva T, Astakhova Z, Bokov I, Rogovaia K, Maksimova V, Petrushina V, Predtechenskaia T: Effectiveness of cefotetan in clinical practice. Antibiot Khimioter 1997;42:16-19.
25. Janda J: Recent advances in the study of the taxonomy, pathogenicity, and infectious syndromes associated with the genus Aeromonas. Clin Microbiol Rev 1991;4:397-410.
26. Isaacs R, Paviour S, Bunker D, Lang S: Wound infections with aerogenic Aeromonas strains: A review of twenty-seven cases. Eur J Clin Microbiol Infect Dis 1988;7:355-360.
27. Janda J, Duffey P: Mesophilic aeromonads in human disease: Current taxonomy, laboratory identification, and infectious disease spectrum. Rev Infect Dis 1988;10:980-997.
28. Jones B, Wilcox M: Aeromonas infections and their treatment. J Antimicrob Chemother 1995;35:453-461.